首页> 外文期刊>Natural Product Radiance (NPR) >Study of the safety profile of raw (a?odhita) and cow’s urine processed (gomūtra ?odhita) tubers of Gloriosa superba L. (Lāngali) in albino rats
【24h】

Study of the safety profile of raw (a?odhita) and cow’s urine processed (gomūtra ?odhita) tubers of Gloriosa superba L. (Lāngali) in albino rats

机译:生(a?odhita)和牛尿的安全性剖面(Gomaktra?Odhita)Gloriosa Superba L.(Lāngali)的尿液(GomaTrala?Odhita)块茎

获取原文
       

摘要

Lāngali (Gloriosa superba L.) is a drug in upavis?a varga (semi-poisonous drug) which has to undergo ?odhana procedure before its therapeutic use. The present study was planned to assess the role of ?odhana of Lāngali tuber by gomūtra on its safety aspects in experimental animals, which is recommended by Ayurvedic Formulary of India. The therapeutic dose of Lāngali as per API is 125 to 250 mg/day. For the present study the higher dose i.e. 250 mg was selected. Wistar strain albino rats were used for the study. The animals were divided into seven groups and each group contained 12 animals (six male and six female). The study was done for 90 days followed by 30 days (total 120 days) recovery study. Various haematological, biochemical parameters and histopathology of the organs were studied. The study showed that ?odhana process attenuates the toxicity producing potential of raw Lāngali. When processed with gomūtra, lāngali root produces good spermatogenic effect while raw/ a?odhita lāngali hampers spermatogenesis at 10 times dose level. So it can be concluded that both raw and ?odhita Langali found relatively safe up to 5 times therapeutic dose level.
机译:Lāngali(Gloriosa Superba L.)是一种upavis的药物?在其治疗用途之前必须经过odhana程序的varga(半毒药)。计划评估Lāngali杜培劳埃利菌革的ODHANA对实验动物的安全方面的作用,这是由印度阿育吠陀的形容性建议的。根据API的lekngali治疗剂量为125至250mg /天。对于本研究,选择较高剂量的剂量即250mg。 Wistar菌株白果大鼠用于研究。将动物分为七组,每组含有12只动物(六只雄性和六个雌性)。该研究进行了90天,然后进行30天(共120天)恢复研究。研究了各种血液学,生化参数和器官的组织病理学。该研究表明,ODHANA过程衰减了生成的毒性Lāngali的潜力。当用GOMūTRA加工时,Lāngali根生成良好的精子效果,而原料/ a?odhitalāngali妨碍了10次剂量水平的精子发生。因此,可以得出结论,生成和odhita langali发现相对安全的治疗剂量水平相对安全。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号